Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Pfizer buys Seagen for $43B, boosts access to cancer drugs

Por: The Advocate Business March 13, 2023

thumbnail

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug developer continue innovating, except with more resources than it would have alone, Pfizer Chairman and CEO Albert Bourla told analysts.We are not buying the golden eggs,... + full article



Similar News

Pfizer CEO says it will be able to deliver Seagen's cancer therapy at a scale not seen before with $43 billion deal

CNBC USA Health March 14, 2023

thumbnailPfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más

Pfizer buys Seagen for $43B, boosts access to cancer drugs | The Advocate

Pfizer buys Seagen for $43B, boosts access to cancer drugs | ABC News


Pfizer to buy cancer drugmaker Seagen in $43 billion deal

Orlando Sentinel USA Business March 13, 2023

thumbnailPfizer Inc. agreed to purchase cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, gaining the company’s antibody drugs that fight tumors. Pfizer will pay $229 a share in cash for Seagen, according a statement Monday, about a third more than the drugmaker’s... + más

Pfizer buys Seagen for $43B, boosts access to cancer drugs | The Advocate

Pfizer buys Seagen for $43B, boosts access to cancer drugs | ABC News


Pfizer buys Seagen for $43B, boosts access to cancer drugs

ABC News USA Business March 13, 2023

thumbnailPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug... + más

Pfizer buys Seagen for $43B, boosts access to cancer drugs | ABC News

Pfizer buys Seagen for $43B, boosts access to cancer drugs | The Advocate


Pfizer buys Seagen for $43b, boosts access to cancer drugs

The Boston Globe USA Business March 13, 2023

thumbnailPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug... + más

Pfizer buys Seagen for $43B, boosts access to cancer drugs | ABC News

Pfizer buys Seagen for $43B, boosts access to cancer drugs | ABC News


Pfizer buys Seagen for $43B, boosts access to cancer drugs

ABC News USA Health March 13, 2023

thumbnailPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug... + más

Pfizer buys Seagen for $43B, boosts access to cancer drugs | ABC News

Pfizer buys Seagen for $43B, boosts access to cancer drugs | The Advocate


Pfizer buys Seagen for $43B, boosts access to cancer drugs

Associated Press USA Health March 13, 2023

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug... + más

Pfizer buys Seagen for $43B, boosts access to cancer drugs | ABC News

Pfizer buys Seagen for $43B, boosts access to cancer drugs | ABC News


Pfizer in talks to acquire Seagen in deal likely valued at more than $30B

Fox Business USA Business February 27, 2023

thumbnailJPMorgan Chase CEO Jamie Dimon discusses the state of the company and macroeconomic picture in an exclusive interview on 'Mornings with Maria.' Pfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the for a big drug... + más

Fact Check: Were the Grammys sponsored by Pfizer? | Newsweek

Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC



About iurex | Privacy Policy | Disclaimer |